About the research project

The Datura project is a multidisciplinary international research project involving four countries in four different sub-Saharan regions, two countries in Southeast Asia and two European academic institutions. It is studying the effect of using a modified TB treatment protocol in severely immunosuppressed TB patients. The name, Datura, is an acronym for:Determination of Adequate TUberculosis Regimen in Adults and Adolescents hospitalised with HIV-associated severe immune suppression.

The project is a collaboration between researchers in Norway, France, Zambia, Guinea, Cameroon, Uganda, Cambodia and Mozambique. It is co-ordinated by a research team at the Centre Hospitalier Universitaire de Montpellier (external link) in France. The project is funded by the European & Developing Countries Clinical Trials Partnership (EDCTP). (external link)Datura also addresses SDG Goal 3 (external link), target 3.3, aiming to end the epidemics of AIDS and TB, among others, by 2030.

Read more about Datura (external link)

Facts about the project

Project name: Determination of Adequate TUberculosis Regimen in Adults and Adolescents hospitalised with HIV-associated severe immune suppression

Period: 2020-

Funding: This project is primarily funded by EDCTP2. EDCTP2 number: RIA2018CO-2515

Project coordinator:  Dr Didier LAUREILLARD, Prof.François-Xavier BLANC.

Co-coordinator UiB: Sven Gudmund Hinderaker

Countries: Zambia, Guinea, Uganda, Cameroon, Cambodia, Mozambique

Partners: Institut national de la santé et de la recherche médicale, INSERM (UMR 1058), Montpellier, France/University of Bergen, Norway/ Centre Hospitalier Universitaire de Nantes, France/ Institut de Recherche pour le Développement (IRD), France/ Mbarara University of Science and Technology, Uganda, Instituto Nacional de Saúde, Mozambique. 

People

Related persons at CIH